UCSF

ZINC04474405

Substance Information

In ZINC since Heavy atoms Benign functionality
December 3rd, 2005 30 Yes

Other Names:

(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide

(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide

(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide; 5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (5Z)-; 5-Heptenamide, 7-(3,5-dihy

(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide; bimatoprost

(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide

prost

prost-

155206-00-1

155206-00-1; Bimatoprost (JAN/USAN/INN); D02724; Lumigan (TN)

15M

17-phenyl trinor Prostaglandin F2.alpha. ethyl amide-d4

17-Phenyl-tri-norprostaglandin F2_-ethyl amide

267244-98-4

5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (5Z)-

5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-

5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-1(alpha(Z),2beta(1E,3S*)3alpha,5alpha))-

5-Heptenamide,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ehtyl-,(5Z)

AC1NSJUW

AGN 192024

AGN-192024

BAN

Bimataprost [USAN:INN:BAN]

Bimatoprost (BAN

Bimatoprost (FDA

Bimatoprost (JAN/USAN/INN)

Bimatoprost [USAN:INN:BAN]

Bimatoprost, 97%+

Bimatoprost-d4

bimatoprost; bimatoprostum

bimatoprostum

CHEBI:39562

CHEBI:51230

CHEMBL1200963

CID5311027

D02724

DAP001217

DB00905

DB06863

FDA

I06-1275

I06-1277

INN

Latisse

LS-181817

Lumigan

Lumigan (TN)

MFCD03411999

NCGC00181745-01

UNII-QXS94885MZ

USAN)

ZINC04474405

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.16 5.24 -13.14 4 5 0 90 415.574 12

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 1.87e-02 g/l DrugBank-approved
Patent Database Links EP1859802; EP1932841; EP1985298; US2005004074; US2007179127; US2007224246; US2007249581; US2007249602; US2007249731; US2007254920; US2007259861; US2007269487; WO2007111806; WO2007123818; WO2007127711 ChEBI
UniProt Database Links PF2R_HUMAN ChEBI

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )